Early markers of allergic disease in a primary prevention study using probiotics: 2.5‐year follow‐up phase

Background:  We previously reported that a Lactobacillus acidophilus probiotic strain (LAFTI® L10/LAVRI‐A1) given for the first 6 months of life increased the risk of allergen sensitization at 1 year of age.

[1]  P. Conway,et al.  Relationship between early intestinal colonization, mucosal immunoglobulin A production and systemic immune development , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[2]  M. Bollinger,et al.  Clinical Effects of Probiotics Are Associated With Increased Interferon-γ Responses in Very Young Children With Atopic Dermatitis , 2007, Pediatrics.

[3]  B. Björkstén,et al.  Probiotics for the prevention or treatment of allergic diseases. , 2007, The Journal of allergy and clinical immunology.

[4]  Julia Baumann.  Down Syndrome Cell Adhesion Molecule – A Common Determinant of Brain and Heart Wiring , 2007, Pediatric Research.

[5]  M. Fredrikson,et al.  Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. , 2007, The Journal of allergy and clinical immunology.

[6]  M. Phillips,et al.  Immune enhancing effects of Lactobacillus acidophilus LAFTI L10 and Lactobacillus paracasei LAFTI L26 in mice. , 2007, International journal of food microbiology.

[7]  W. Thomas,et al.  FOXP3 mRNA expression at 6 months of age is higher in infants who develop atopic dermatitis, but is not affected by giving probiotics from birth , 2007, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[8]  S. Prescott,et al.  Effects of probiotic supplementation for the first 6 months of life on allergen‐ and vaccine‐specific immune responses , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[9]  S. Prescott,et al.  Evaluation of the effects of probiotic supplementation from the neonatal period on innate immune development in infancy , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[10]  J. Upham,et al.  Toll-like receptor 2 ligands inhibit TH2 responses to mite allergen. , 2006, The Journal of allergy and clinical immunology.

[11]  B. Brunekreef,et al.  Prenatal farm exposure is related to the expression of receptors of the innate immunity and to atopic sensitization in school-age children. , 2006, The Journal of allergy and clinical immunology.

[12]  D. Pyne,et al.  Reversal in fatigued athletes of a defect in interferon γ secretion after administration of Lactobacillus acidophilus , 2006, British Journal of Sports Medicine.

[13]  S. Prescott,et al.  Clinical effects of probiotics are associated with increased interferon‐γ responses in very young children with atopic dermatitis , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[14]  S. Elahi,et al.  Enhanced clearance of Candida albicans from the oral cavities of mice following oral administration of Lactobacillus acidophilus , 2005, Clinical and experimental immunology.

[15]  T. Haahtela,et al.  Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome. , 2005, The Journal of allergy and clinical immunology.

[16]  S. Prescott,et al.  Effects of probiotics on atopic dermatitis: a randomised controlled trial , 2005, Archives of Disease in Childhood.

[17]  T. Haahtela,et al.  Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double‐blind placebo‐controlled trial , 2005, Allergy.

[18]  R. Korpela,et al.  Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy. , 2004, The Journal of allergy and clinical immunology.

[19]  Thomas Bieber,et al.  Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. , 2004, The Journal of allergy and clinical immunology.

[20]  P. Holt,et al.  Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. , 2003, The Journal of allergy and clinical immunology.

[21]  R. Gangnon,et al.  Developmental cytokine response profiles and the clinical and immunologic expression of atopy during the first year of life. , 2003, The Journal of allergy and clinical immunology.

[22]  S. Salminen,et al.  Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial , 2003, The Lancet.

[23]  K. Michaelsen,et al.  Effect of probiotic lactobacillus strains in children with atopic dermatitis , 2003, The Journal of allergy and clinical immunology.

[24]  J. Warrington,et al.  Identification and validation of endogenous reference genes for expression profiling of T helper cell differentiation by quantitative real-time RT-PCR. , 2001, Analytical biochemistry.

[25]  S. Salminen,et al.  Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial , 2001, The Lancet.

[26]  S. Salminen,et al.  Probiotics in the management of atopic eczema , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[27]  P. Sly,et al.  Development of allergen-specific T-cell memory in atopic and normal children , 1999, The Lancet.

[28]  Prescott,et al.  Reciprocal age‐related patterns of allergen‐specific T‐cell immunity in normal vs. atopic infants , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[29]  Shinoda,et al.  Reduced interferon gamma production by antigen‐stimulated cord blood mononuclear cells is a risk factor of allergic disorders — 6‐year follow‐up study , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[30]  E. Isolauri,et al.  Probiotics: a novel approach in the management of food allergy. , 1997, The Journal of allergy and clinical immunology.

[31]  F. Martinez,et al.  Association of interleukin-2 and interferon-gamma production by blood mononuclear cells in infancy with parental allergy skin tests and with subsequent development of atopy. , 1995, The Journal of allergy and clinical immunology.

[32]  A. Kemp,et al.  Reduced interferon-γ secretion in neonates and subsequent atopy , 1994, The Lancet.

[33]  J. Warner,et al.  Is deficiency of interferon gamma production by allergen triggered cord blood cells a predictor of atopic eczema? , 1994, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[34]  G. Rajka,et al.  Diagnostic Features of Atopic Dermatitis , 1980, Acta Dermato-Venereologica.

[35]  S. Prescott,et al.  Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. , 2007, The Journal of allergy and clinical immunology.

[36]  P. Holt,et al.  Postnatal Development of Monocyte Cytokine Responses to Bacterial Lipopolysaccharide , 2007, Pediatric Research.

[37]  T. Haahtela,et al.  Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. , 2007, The Journal of allergy and clinical immunology.

[38]  A. Kemp,et al.  Reduced interferon-gamma secretion in neonates and subsequent atopy. , 1994, Lancet.

[39]  Julia Brasch,et al.  Severity Scoring of Atopic Dermatitis: The SCORAD Index , 1993 .

[40]  A. Taïeb,et al.  Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. , 1993, Dermatology.

[41]  Lorian,et al.  ENVIRONMENTAL EXPOSURE TO ENDOTOXIN AND ITS RELATION TO ASTHMA IN SCHOOL-AGE CHILDREN , 2022 .